SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kintara Therapeutics, Inc. – ‘8-K’ for 8/2/22 – ‘XML’

On:  Wednesday, 8/3/22, at 4:06pm ET   ·   For:  8/2/22   ·   Accession #:  950170-22-14228   ·   File #:  1-37823

Previous ‘8-K’:  ‘8-K’ on 6/22/22 for 6/21/22   ·   Next:  ‘8-K’ on / for 9/27/22   ·   Latest:  ‘8-K’ on / for 4/25/24   ·   7 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/03/22  Kintara Therapeutics, Inc.        8-K:1,8,9   8/02/22   14:1M                                     Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     97K 
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     24K 
 3: EX-10.1     Material Contract                                   HTML    524K 
 4: EX-10.2     Material Contract                                   HTML    171K 
 5: EX-99.1     Miscellaneous Exhibit                               HTML     22K 
 9: R1          Document and Entity Information                     HTML     48K 
12: XML         IDEA XML File -- Filing Summary                      XML     13K 
10: XML         XBRL Instance -- ktra-20220802_htm                   XML     16K 
11: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 8: EX-101.LAB  XBRL Labels -- ktra-20220802_lab                     XML     56K 
 6: EX-101.PRE  XBRL Presentations -- ktra-20220802_pre              XML     36K 
 7: EX-101.SCH  XBRL Schema -- ktra-20220802                         XSD     12K 
13: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    20K 
14: ZIP         XBRL Zipped Folder -- 0000950170-22-014228-xbrl      Zip    118K

‘XML’   —   XBRL Instance — ktra-20220802_htm

This Document is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="ktra-20220802.xsd" xlink:type="simple"/>
<context id="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001498382 </identifier>
</entity>
<period>
<startDate> 2022-08-02 </startDate>
<endDate> 2022-08-02 </endDate>
</period>
</context>
<dei:AmendmentFlag contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_6456776e-bc5e-423d-be45-6c40d15ad02c"> false </dei:AmendmentFlag>
<dei:EntityCentralIndexKey contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_8f81f114-a419-4989-9f53-2154f8d2eede"> 0001498382 </dei:EntityCentralIndexKey>
<dei:DocumentType contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_aaf82389-f251-4225-8a7e-7a9349909f89"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_62bd1b9f-ba84-4fe7-8ec8-782d34acb597"> 2022-08-02 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_118532bd-18d9-449f-957a-deade363ffc9"> KINTARA THERAPEUTICS, INC. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_5a3f42cb-93c2-4ce0-ac0e-b84ac1711e5c"> NV </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_727bb1d5-15df-4d55-857c-3827037dc31e"> 001-37823 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_2b826955-1e4c-4992-9ca0-2fabb0b90d9f"> 99-0360497 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_b12d02fd-cd53-4c8c-b5aa-f039f31216ce"> 9920 Pacific Heights Blvd </dei:EntityAddressAddressLine1>
<dei:EntityAddressAddressLine2 contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_8336ebb2-8b53-421c-aa17-eb2b8b2d384a"> Suite 150 </dei:EntityAddressAddressLine2>
<dei:EntityAddressCityOrTown contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_b5a2c963-77ea-4dfd-95be-24b8ad6001b2"> San Diego </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_f9526a98-c008-4e97-9463-ab82e693e0a1"> CA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_3802da87-ba1c-4b5b-9721-b1d0e8b35e04"> 92121 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_e6f8abea-ed90-4922-a843-3e01f9872483"> 858 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_eeda4624-c84e-414e-a432-adc9577e6986"> 350-4364 </dei:LocalPhoneNumber>
<dei:WrittenCommunications contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_1e33665f-240f-47a1-8b87-2c957d6c64bf"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_18fa2888-0a41-464e-b2b7-91c6e48b263e"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_512dfa41-5a01-4d53-9f59-49f957c6ba28"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_db036d2c-6914-465d-aed1-063a30c283eb"> false </dei:PreCommencementIssuerTenderOffer>
<dei:Security12bTitle contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_46cbeb57-ff6c-43f2-abe1-39480de13f49"> Common Stock </dei:Security12bTitle>
<dei:TradingSymbol contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_b8389306-494c-41c1-a854-efa46722beb9"> KTRA </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_f6006a44-1b79-4968-943e-e501f4b60aca"> NASDAQ </dei:SecurityExchangeName>
<dei:EntityEmergingGrowthCompany contextRef="C_e9b9a952-1f25-4449-b4fc-fdc0622f6b04" id="F_22de47e4-9563-4b8d-abec-25b4f3a83383"> false </dei:EntityEmergingGrowthCompany>
</xbrl>

7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/27/23  Kintara Therapeutics, Inc.        S-1/A                 12:1.2M                                   Donnelley … Solutions/FA
10/24/23  Kintara Therapeutics, Inc.        S-1/A                 20:2.4M                                   Donnelley … Solutions/FA
10/04/23  Kintara Therapeutics, Inc.        S-1                   13:1.1M                                   Donnelley … Solutions/FA
 9/18/23  Kintara Therapeutics, Inc.        10-K        6/30/23   75:12M                                    Donnelley … Solutions/FA
11/09/22  Kintara Therapeutics, Inc.        10-Q        9/30/22   58:8.8M                                   Donnelley … Solutions/FA
 9/27/22  Kintara Therapeutics, Inc.        S-8         9/27/22    4:271K                                   Donnelley … Solutions/FA
 9/27/22  Kintara Therapeutics, Inc.        10-K        6/30/22   79:15M                                    Donnelley … Solutions/FA
↑Top
Filing Submission 0000950170-22-014228   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 27, 8:51:05.2pm ET